Additionally, the serum levels of ALT, which is the standard indicator of liver function and is used to reflect hepatic injury and inflammation in patients with chronic liver diseases [56] and cholesterol homeostasis dysfunction, were documented in NAFLD [57]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.